Skip to content
Main Menu
Excelsior
About Excelsior Medical
Enterprise Spirit
Development Strategy
Related Company
Overseas Business
Company History
Product Description
Hemodialysis / Plasma Exchange
Blood Bag
Artificial Stoma
Health Appliances
ESG
Investors
Enterprise Recruitment
Contact Us
Monthly Sales-2026.02
Item
Net Revenue
2026.02
695,983
2025.02
720,743
MoM Change
-24,760
MoM Change (%)
-3.44
2026 1-2
1,501,303
2025 1-2
1,416,370
YoY Change
84,933
YoY Change (%)
6.00
Note
Prev
PREVIOUS
Announcement of the resolution by the Company for the ex-dividend record date of cash dividends.
NEXT
Announcement on behalf of major subsidiary,Excelsior Asset Management Co., Ltd., regarding BOD Resolution on capital increase by earnings recapitalization
Next
Investors
Material Information
Board of Directors
Corporate Governance
Organization
Major Internal Policies
Corporate Governance
Committee
Audit Committee
Remuneration Committee
Financial Information
Monthly Revenue
Financial Statements
Shareholder Services
Shareholders' Meeting
Institutional Investor Conference
Dividend
Stock Quotes
Stock Transfer Agent and Registrar
Contacts
Stakeholders
Investors
